HealthLynked (HLYK) – Investor Forum at the World Stem Cell Summit

HealthLynked Founder and CEO Dr. Michael Dent delivers a formal corporate overview, followed by a Q & A session moderated by a Noble Capital Markets equity research representative.

About HealthLynked Corp.

It is our mission to improve healthcare by the transfer of accurate medical information between patients and their healthcare providers, improving medical practice efficiency, increasing access to quality healthcare, and facilitating accurate medical diagnosis.

HealthLynked was launched in Naples, Florida, in 2016 by Dr. Michael Dent, the visionary behind NeoGenomics, now one of the largest genetic cancer testing facilities in the world. After spending nearly thirty years as a practicing physician, he wanted to find a way to make data sharing, patient management, and research easier and more accessible to more people and physicians.

In the pursuit of improving healthcare, HealthLynked has created multiple apps and services for patients including the HealthLynked app, COVID-Tracker app, Oohvie, a Period Tracker and Ovulation Calendar app, DocLynk Telemedicine, CareLynk, and LYNKfit Wearable Health Sensor. For Providers, HealthLynked has created multiple applications like Patient Access Hub, QwikCheck, and more to help providers grow and improve their practice. HealthLynked is the parent company of Naples Women’s Center, Naples Center for Functional Medicine, Bridging the Gap Physical Therapy, MedOfficeDirect, and Cura Health Management, LLC.

HealthLynked is improving healthcare for every patient worldwide. In the hopes of creating a better healthcare system, HealthLynked plans on improving healthcare by integrating customer histories, genetics, and demographics into an artificial intelligence-driven system that coordinates patient care and looks for trends in large populations. The end result is a healthier, more connected network of people and providers.